The therapy ofNON-MUSCLE INVASIVE URBAN CARCINOMASaccording to the S3 guideline in a practical overview.App as a free download for specialist groups with Doc Check Login!About this app• Offers you help with risk classification, therapy and aftercare• Takes into account the S3 guideline of non-muscle invasive bladder cancer• Read and commented for you: The publication of the monthThe BC Care app from medac is an interactive, mobile aid for identifying the risk group for superficial non-muscle-invasive bladder carcinoma (NMIBC) and provides information for guideline-oriented, risk-adapted therapy. Based on the currently valid S3 guideline on non-muscle-invasive bladder cancer (Ta, T1, CIS), the BC Care app offers valuable support in daily urological practice.Additional information in the app:• Technical information on mito-extra® and BCG-medac• The S3 guideline of 2020• Glossary of all important HBCA termsA service of the medac society for clinical specialty products mbH
BC Care medac
